V

VRTX

VRTX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
VRTX Live QuoteReal-time
$520.66
$3.86(-0.74%)1M
Day Range$517.82 – $537.79
Open$537.79
Previous Close$536.45
Volume1.18M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$136.01B
P/E Ratio (TTM)34.5
Forward P/E26.1
EPS (TTM)$15.54
Price to Book6.5
Dividend Yield0.65%
Beta (Volatility)0.28
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $520.66 (69%)
Low: $412.27High: $568.67
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$595.36+296.9% upside

Insider Buys

0

$0

Insider Sales

1

$6.31M

Total Volume

$6.31M

1 transactions

Net Activity

$6.31M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
K
1

Kewalramani Reshma

CEO, Pres

0 buys1 sells

$6.31M total

Trading History
VRTX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 6, 2026

2 weeks ago

Kewalramani Reshma

CEO, Pres

CEO
Sell11.9K$531.53$6.31M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
VRTX Buy Conviction0%
Industry Rank#171 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

VRTX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. VRTX ranks #171 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for VRTX

Over the last 90 days, corporate insiders at VRTX (VRTX) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $6.31M.

The net insider activity for VRTX shows a net selling bias of $6.31M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Kewalramani Reshma (CEO, Pres), who traded 11.9K shares valued at $6.31M on Nov 6, 2026.

Live Market News & Developments
Aggregated real-time headlines for VRTX (VRTX)
6 updates

Has Vertex Stock Become A Different Bet?

Trefis1h ago

Vertex Pharmaceuticals (VRTX) Stock May Be Undervalued After Its 187% Run

Yahoo Finance2d ago

Vertex Pharmaceuticals Stock Price Forecast. Should You Buy VRTX?

StockInvest.us4d ago

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.17% on Nov 19: Facts Behind the Movement

TradingKey15h ago

Why Vertex Stock Just Triggered A Sell Rule

Investor's Business Daily17d ago

Vertex Pharmaceuticals(VRTX.US) Officer Sells US$8.37 Million in Common Stock

Moomoo2d ago

FAQs About VRTX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for VRTX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for VRTX is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for VRTX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.